MEMPHIS PHARMACEUTICALSMEMPHIS PHARMACEUTICALSMEMPHIS PHARMACEUTICALS

MEMPHIS PHARMACEUTICALS

No trades
See on Supercharts
Market capitalization
‪540.06 M‬EGP
‪90.44 M‬EGP
‪663.83 M‬EGP
‪1.21 M‬
Beta (1Y)
−0.35

About MEMPHIS PHARMACEUTICALS

CEO
Basem Mohamed Abdullah
Headquarters
Cairo
Founded
1940
ISIN
EGS38351C010
FIGI
BBG000HGL3D1
Memphis Pharmaceutical & Chemical Industries engages in the manufacture of medicines and other pharmaceutical products for human and veterinary use. Its products include effervescent tablets, syrup, cream, injections, tablet and capsules, and suppository. The company was founded on July 20, 1940 and is headquartered in Cairo, Egypt.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MPCI is 90.730 EGP — it has decreased by 6.83% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EGX exchange MEMPHIS PHARMACEUTICALS stocks are traded under the ticker MPCI.
MPCI stock is 11.83% volatile and has beta coefficient of −0.35. Check out the list of the most volatile stocks — is MEMPHIS PHARMACEUTICALS there?
Yes, you can track MEMPHIS PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
MPCI stock has risen by 0.74% compared to the previous week, the month change is a 8.74% fall, over the last year MEMPHIS PHARMACEUTICALS has showed a 226.72% increase.
MPCI net income for the last quarter is ‪58.12 M‬ EGP, while the quarter before that showed ‪24.76 M‬ EGP of net income which accounts for 134.71% change. Track more MEMPHIS PHARMACEUTICALS financial stats to get the full picture.
Today MEMPHIS PHARMACEUTICALS has the market capitalization of ‪540.06 M‬, it has decreased by 2.94% over the last week.
Yes, MPCI dividends are paid annually. The last dividend per share was 2.00 EGP. As of today, Dividend Yield (TTM)% is 2.08%. Tracking MEMPHIS PHARMACEUTICALS dividends might help you take more informed decisions.
MEMPHIS PHARMACEUTICALS dividend yield was 6.46% in 2023, and payout ratio reached 12.44%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MPCI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEMPHIS PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
MPCI reached its all-time high on Mar 3, 2024 with the price of 139.990 EGP, and its all-time low was 0.667 EGP and was reached on Jun 3, 2008.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEMPHIS PHARMACEUTICALS technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEMPHIS PHARMACEUTICALS stock shows the buy signal. See more of MEMPHIS PHARMACEUTICALS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEMPHIS PHARMACEUTICALS EBITDA is ‪192.00 M‬ EGP, and current EBITDA margin is 21.21%. See more stats in MEMPHIS PHARMACEUTICALS financial statements.